Thor Medical ASA: Invitation to Presentation of Half-Year 2026 Results

19.8.2026 07:00:08 CEST | Thor Medical ASA | Non-regulatory press releases

Thor Medical ASA will publish its financial results for the first half of 2026 on Friday, August 28, 2026, at 07:00 CEST.

The company will host a presentation of the results at 08:00 CEST on the same day at Sjølyst Møtesenter, Drammensveien 165, Oslo. Investors, analysts and media are invited to attend.

Date: Friday, August 28, 2026 Time: 08:00 CEST Venue: Sjølyst Møtesenter, Drammensveien 165, Oslo Webcast: https://qcnl.tv/p/fw_5KqTHcjfYMddAq3--1A

The financial report for the first half of 2026 and the presentation material will be published at 07:00 CEST and will be available at www.thormedical.com - http://www.thormedical.com/.

CONTACTS

* Mathias Nilsen Reierth, Head of Communications and Corporate Affairs, +47 988 05 724, mathias.reierth@thormedical.com

ABOUT THOR MEDICAL ASA

ABOUT THOR MEDICAL ASA

Thor Medical is a leading supplier of high-purity isotopes to the radiopharmaceutical industry. The Company's proprietary production platform combines advanced separation technology with industrial-scale manufacturing capacity to deliver a reliable, scalable and cost-efficient supply of alpha-emitting radioisotopes. Thor Medical supports radiopharmaceutical companies from early-stage development to commercialization enabling scale-up of next-generation targeted cancer therapies.

Thor Medical's product portfolio includes lead-212 (Pb-212) and its precursor isotopes thorium-228 (Th-228) and radium-224 (Ra-224). Based on naturally occurring thorium, Thor Medical's production process requires neither irradiation nor nuclear reactors, providing significant cost advantages while minimizing radioactive waste.

Guided by its vision to become a world-leading enabler for targeted cancer therapies, Thor Medical is committed to improving millions of lives by powering the next generation of precision cancer treatment with high-purity isotopes.

Thor Medical is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange under the ticker symbol TRMED. For more information, visit www.thormedical.com - http://www.thormedical.com.

ATTACHMENTS

Download announcement as PDF.pdf - https://kommunikasjon.ntb.no/ir-files/17848634/19028648/15346/Download%20announc ement%20as%20PDF.pdf